Crespo-Leiro, María GenerosaDelgado Jiménez, Juan FranciscoLópez, L.Alonso-Pulpón, LuisGonzález-Vílchez, FranciscoAlmenar-Bonet, LuisRábago Juan-Aracil, GregorioPérez-Villa, FélixPaniagua-Martín, María J.Arizón, JMSousa-Casasnovas, IagoManito-Lorite, NicolásDíaz-Molina, BeatrizPascual Figal, Domingo A.Lage-Gallé, ErnestoBlasco-Peiró, TeresaDe la Fuente-Galán, LuisMuñiz, Javier2015-06-162014-10-01Crespo-Leiro MG, Delgado-Jiménez J, López L. The falling incidence of hematologic cancer after heart transplantation. Clin Transplant. 2014;28:1142-1147http://hdl.handle.net/2183/14682[Abstract] Background. A number of changes in the management of heart transplantation (HT) patients have each tended to reduce the risk of post-HT hematologic cancer, but little information is available concerning the overall effect on incidence in the HT population. Methods. Comparison of data from the Spanish Post-Heart-Transplantation Tumour Registry for the periods 1991–2000 and 2001–2010. Results. The incidence among patients who underwent HT in the latter period was about half that observed in the former, with a particularly marked improvement in regard to incidence more than five yr post-HT. Conclusions. Changes in HT patient management have jointly reduced the risk of hematologic cancer in the Spanish HT population. Long-term risk appears to have benefited more than short-term risk.engThis is the peer reviewed version of the following article which has been published in final form at Wiley Online Library. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for self-archivingCancer incidenceHeart transplantationImmunodepressive therapyLong-term complicationsLymphomasMortalityjournal articleopen access